Published in Lancet on September 21, 2004
Mycobacterium avium in the postgenomic era. Clin Microbiol Rev (2007) 2.65
NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog (2005) 2.04
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. J Clin Microbiol (2007) 1.54
Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut (2005) 1.51
Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 1.48
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. Antimicrob Agents Chemother (2012) 1.48
Genomic polymorphisms for Mycobacterium avium subsp. paratuberculosis diagnostics. J Clin Microbiol (2005) 1.45
Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol (2005) 1.43
Mycobacterium in Crohn's: something to ruminate about? Gastroenterology (2005) 1.41
Mycobacterium avium subsp. paratuberculosis in the catchment area and water of the River Taff in South Wales, United Kingdom, and its potential relationship to clustering of Crohn's disease cases in the city of Cardiff. Appl Environ Microbiol (2005) 1.38
Mycobacterium avium subsp. paratuberculosis in lake catchments, in river water abstracted for domestic use, and in effluent from domestic sewage treatment works: diverse opportunities for environmental cycling and human exposure. Appl Environ Microbiol (2006) 1.37
Antibodies recognizing Mycobacterium avium paratuberculosis epitopes cross-react with the beta-cell antigen ZnT8 in Sardinian type 1 diabetic patients. PLoS One (2011) 1.34
Whole-genome plasticity among Mycobacterium avium subspecies: insights from comparative genomic hybridizations. J Bacteriol (2006) 1.33
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24
A molecular revolution in the study of intestinal microflora. Gut (2006) 1.18
Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario. Gut Pathog (2009) 1.17
Defining the stressome of Mycobacterium avium subsp. paratuberculosis in vitro and in naturally infected cows. J Bacteriol (2007) 1.17
Discovery of stable and variable differences in the Mycobacterium avium subsp. paratuberculosis type I, II, and III genomes by pan-genome microarray analysis. Appl Environ Microbiol (2008) 1.15
On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. PLoS One (2007) 1.14
Replication and long-term persistence of bovine and human strains of Mycobacterium avium subsp. paratuberculosis within Acanthamoeba polyphaga. Appl Environ Microbiol (2006) 1.14
On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. PLoS One (2007) 1.14
The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver (2010) 1.12
Comparison of four different culture media for isolation and growth of type II and type I/III Mycobacterium avium subsp. paratuberculosis strains isolated from cattle and goats. Appl Environ Microbiol (2006) 1.12
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours. Appl Environ Microbiol (2007) 1.08
Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol (2009) 1.06
Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J (2013) 1.06
Development of a bovine ileal cannulation model to study the immune response and mechanisms of pathogenesis of paratuberculosis. Clin Vaccine Immunol (2009) 1.06
Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus. PLoS One (2009) 1.06
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS One (2008) 1.04
Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis? Yonsei Med J (2016) 1.03
Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol Infect (2007) 1.03
Polymorphisms in gyrA and gyrB genes among Mycobacterium avium subsp. paratuberculosis type I, II, and III isolates. J Clin Microbiol (2007) 1.03
Evaluation of in situ methods used to detect Mycobacterium avium subsp. paratuberculosis in samples from patients with Crohn's disease. J Clin Microbiol (2006) 1.02
Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog (2009) 1.02
Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens. J Microbiol Methods (2006) 1.01
Identification and characterization of a spore-like morphotype in chronically starved Mycobacterium avium subsp. paratuberculosis cultures. PLoS One (2012) 1.01
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob Agents Chemother (2007) 1.00
Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. World J Gastroenterol (2014) 0.99
Culture phenotypes of genomically and geographically diverse Mycobacterium avium subsp. paratuberculosis isolates from different hosts. J Clin Microbiol (2011) 0.99
Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease. Vaccine (2011) 0.98
Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol (2007) 0.97
Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci (2006) 0.96
Application of bacteriophages for detection of foodborne pathogens. Bacteriophage (2014) 0.95
Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol (2008) 0.95
Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease. PLoS One (2008) 0.95
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective. Can J Gastroenterol (2010) 0.94
Emerging infectious determinants of chronic diseases. Emerg Infect Dis (2006) 0.94
Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain? Gut Pathog (2010) 0.94
Insertion sequence IS900 revisited. J Clin Microbiol (2006) 0.94
High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol (2010) 0.93
"In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis. Ann Clin Microbiol Antimicrob (2006) 0.92
Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol (2009) 0.91
Mycobacterium avium subsp. paratuberculosis in an Italian cohort of type 1 diabetes pediatric patients. Clin Dev Immunol (2012) 0.91
Optimization of a phage amplification assay to permit accurate enumeration of viable Mycobacterium avium subsp. paratuberculosis cells. Appl Environ Microbiol (2009) 0.90
Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: destination Sardinia, or beyond? Gut Pathog (2010) 0.90
On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. PLoS One (2008) 0.89
Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study. Gut Pathog (2013) 0.89
Fecal detection of Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohn's disease and ulcerative colitis patients and healthy subjects. Dig Dis Sci (2011) 0.89
Isolation of Mycobacterium avium subspecies paratuberculosis from Ugandan cattle and strain differentiation using optimised DNA typing techniques. BMC Vet Res (2012) 0.88
A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis. PLoS One (2007) 0.88
Genome-Wide Sequence Variation among Mycobacterium avium Subspecies paratuberculosis Isolates: A Better Understanding of Johne's Disease Transmission Dynamics. Front Microbiol (2011) 0.88
Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model. Clin Vaccine Immunol (2013) 0.88
Ovine paratuberculosis: a seroprevalence study in dairy flocks reared in the marche region, Italy. Vet Med Int (2011) 0.87
Anti-inflammatory and antiapoptotic responses to infection: a common denominator of human and bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis. Biomed Res Int (2013) 0.87
Dysbiotic events in gut microbiota: impact on human health. Nutrients (2014) 0.87
Subspecies identification and significance of 257 clinical strains of Mycobacterium avium. J Clin Microbiol (2014) 0.86
Evaluation of a Salmonella vectored vaccine expressing Mycobacterium avium subsp. paratuberculosis antigens against challenge in a goat model. PLoS One (2013) 0.86
RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis. Gut Pathog (2016) 0.85
Influence of Mycobacterium avium subsp. paratuberculosis on colitis development and specific immune responses during disease. Infect Immun (2007) 0.85
Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J Clin Microbiol (2007) 0.85
Oxidative stress due to Mycobacterium avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx activity. Gut Pathog (2016) 0.85
Development of a rapid phage-based method for the detection of viable Mycobacterium avium subsp. paratuberculosis in blood within 48 h. J Microbiol Methods (2013) 0.85
Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at the early but not at the late stage of infection. Infect Immun (2008) 0.84
A biosensor assay for the detection of Mycobacterium avium subsp. paratuberculosis in fecal samples. J Vet Sci (2009) 0.84
Pathogenesis of Crohn's disease: Bug or no bug. World J Gastrointest Pathophysiol (2015) 0.84
Mycobacterium avium subspecies Paratuberculosis and Crohn's regional ileitis: how strong is association? J Lab Physicians (2011) 0.84
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn's disease, cause or epiphenomenon? World J Gastroenterol (2014) 0.83
NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World J Gastroenterol (2011) 0.83
The Association of Mycobacterium avium subsp. paratuberculosis with Inflammatory Bowel Disease. PLoS One (2016) 0.82
Highly specific and quick detection of Mycobacterium avium subsp. paratuberculosis in feces and gut tissue of cattle and humans by multiple real-time PCR assays. J Clin Microbiol (2011) 0.82
Rapid and sensitive detection of an intracellular pathogen in human peripheral leukocytes with hybridizing magnetic relaxation nanosensors. PLoS One (2012) 0.82
Genetic adult lactase persistence is associated with risk of Crohn's Disease in a New Zealand population. BMC Res Notes (2010) 0.82
Expression of a Gene Encoding 34.9 kDa PPE Antigen of Mycobacterium avium subsp. paratuberculosis in E. coli. Mol Biol Int (2010) 0.82
Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role. Dig Dis Sci (2011) 0.81
Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis. BMC Gastroenterol (2011) 0.81
Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis. Appl Environ Microbiol (2008) 0.81
Vitamins A & D inhibit the growth of mycobacteria in radiometric culture. PLoS One (2012) 0.81
Tumour necrosis factor-alpha production stimulated by heat shock protein 70 and its inhibition in circulating dendritic cells and cells eluted from mucosal tissues in Crohn's disease. Clin Exp Immunol (2006) 0.81
Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease? Dig Dis Sci (2017) 0.81
Human inflammatory bowel disease does not associate with Lawsonia intracellularis infection. BMC Microbiol (2006) 0.81
Uptake and persistence of Mycobacterium avium subsp. paratuberculosis in human monocytes. Infect Immun (2012) 0.80
Virulence and immunity orchestrated by the global gene regulator sigL in Mycobacterium avium subsp. paratuberculosis. Infect Immun (2014) 0.80
Detection of Mycobacterium avium ss. Paratuberculosis in Blau Syndrome Tissues. Autoimmune Dis (2010) 0.80
Adherent-invasive Escherichia coli target the epithelial barrier. Gut Microbes (2010) 0.80
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World J Gastroenterol (2008) 0.80
Immunopathogenesis of granulomas in chronic autoinflammatory diseases. Clin Transl Immunology (2016) 0.80
Sargramostim for active Crohn's disease. N Engl J Med (2005) 2.24
Evaluation of surgical tissue from patients with Crohn's disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis (2005) 1.68
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2012) 1.57
Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis (2003) 1.57
Stent-assisted endovascular recanalization of extracranial internal carotid artery occlusion in acute ischemic stroke. World Neurosurg (2012) 1.44
Causes of coral reef degradation. Science (2003) 1.08
Competitive interactions between invasive Nile tilapia and native fish: the potential for altered trophic exchange and modification of food webs. PLoS One (2010) 1.05
Randomized, controlled trial of standard, large-capacity versus jumbo biopsy forceps for polypectomy of small, sessile, colorectal polyps. Gastrointest Endosc (2012) 1.02
Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis. Am J Gastroenterol (2007) 0.99
Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J (2014) 0.97
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging. Am J Gastroenterol (2013) 0.96
Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5. Dig Dis Sci (2007) 0.91
Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease. Am J Gastroenterol (2007) 0.91
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis (2012) 0.88
CT perfusion-guided versus time-guided mechanical recanalization in acute ischemic stroke patients. Clin Neurol Neurosurg (2013) 0.87
Briakinumab for treatment of Crohn's disease: results of a randomized trial. Inflamm Bowel Dis (2015) 0.86
Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease. Inflamm Bowel Dis (2010) 0.86
Certified and uncertified logging concessions compared in Gabon: changes in stand structure, tree species, and biomass. Environ Manage (2013) 0.84
Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn's disease patients. Med Sci Monit (2006) 0.84
Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate vitamin B-12 status. Am J Clin Nutr (2007) 0.82
Radiosurgery for dural arterio-venous fistulas: a review. Clin Neurol Neurosurg (2013) 0.81
Antibodies to CBir1 are associated with glycogen storage disease type Ib. J Pediatr Gastroenterol Nutr (2010) 0.81
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans. Am J Gastroenterol (2009) 0.80
Synthesis and biological evaluation of new citrate-based siderophores as potential probes for the mechanism of iron uptake in mycobacteria. J Med Chem (2002) 0.80
Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases. Inflamm Bowel Dis (2015) 0.80
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World J Gastroenterol (2008) 0.80
Redefining Onyx HD 500 in the Flow Diversion Era. Int J Vasc Med (2011) 0.79
Management of incidental cavernous malformations: a review. Neurosurg Focus (2011) 0.79
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget (2015) 0.79
Treatment of Crohn's disease with budesonide: this rose still has thorns! Am J Gastroenterol (2002) 0.75
Cellular infiltration and cytokine expression correlate with fistulizing state in Crohn's disease. Clin Vaccine Immunol (2011) 0.75
Inflammatory bowel disease education: I can hear the extension for community healthcare outcomes. Inflamm Bowel Dis (2015) 0.75
Treatment of chronic hepatitis C in patients with Crohn's disease. Gastroenterol Hepatol (N Y) (2010) 0.75
Building interdisciplinary frameworks: The importance of institutions, scale, and politics. Proc Natl Acad Sci U S A (2011) 0.75
Synthesis and biological evaluation of new acinetoferrin homologues for use as iron transport probes in mycobacteria. J Med Chem (2004) 0.75